W. Harrison

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
W M Harrison, W. M. Harrison, Wilma M. Harrison, W Harrison, Wilma M Harrison, Wilma Harrison, W. Harrison
Publication record
97 papers · 9,210 citations · H-index 46

PAPERS

A Subgroup of Depressives with Better Response to MAOI than to Tricyclic Antidepressants or Placebo
20186 citationsauthor #8
Platelet/Endothelial Biomarkers in Depressed Patients Treated With the Selective Serotonin Reuptake Inhibitor Sertraline After Acute Coronary Events: The Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy
2003355 citationsauthor #10
Chronic depression and comorbid personality disorders: response to sertraline versus imipramine.
200362 citationsauthor #5
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression.
2002140 citationsauthor #15
Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo.
200277 citationsauthor #8
Sertraline treatment of major depression in patients with acute MI or unstable angina.
20021,455 citationsauthor #15
Dr. Hellerstein and Colleagues Reply
20020 citationsauthor #5
Effects of zoloft® on platelet/endothelial biomarkers in depressed patients after acute coronary events: Sertraline Anti-Depressant Heart Attack Randomized Trial (SADHART platelet substudy)
20022 citationsauthor #9
Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression
200181 citationsauthor #5
Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors.
200180 citationsauthor #4
Gender differences in chronic major and double depression.
2000465 citationsauthor #10
Gender differences in treatment response to sertraline versus imipramine in chronic depression.
2000684 citationsauthor #9
An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial.
1999164 citationsauthor #8
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.
1998333 citationsauthor #11
Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
1998133 citationsauthor #6
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.
199861 citationsauthor #5
Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
1997174 citationsauthor #12
Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers.
1997128 citationsauthor #4
Symptomatic Improvement of Premenstrual Dysphoric Disorder With Sertraline Treatment: A Randomized Controlled Trial
1997227 citationsauthor #12
A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
1997118 citationsauthor #4
P.1.143 Obsessive-compulsive disorder with comorbid major depression: A comparison of sertraline and desipramine treatment
19973 citationsauthor #2
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
1996199 citationsauthor #8
Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another?
199594 citationsauthor #2
Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community.
199585 citationsauthor #2
Duration of antidepressant trials: clinical and research implications.
199426 citationsauthor #5
Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine.
1994196 citationsauthor #4
Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness.
1994121 citationsauthor #3
Chronic depression: response to placebo, imipramine, and phenelzine.
199344 citationsauthor #5
Imipramine treatment of alcoholism with comorbid depression.
1993109 citationsauthor #5
Sodium lactate infusion in late luteal phase dysphoric disorder.
199339 citationsauthor #3
Pharmacotherapy of Dysthymia
199321 citationsauthor #1
Columbia Atypical Depression
1993129 citationsauthor #8
Predictive value of symptoms of atypical depression for differential drug treatment outcome.
199267 citationsauthor #3
Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design.
1991104 citationsauthor #2
Treatment of premenstrual dysphoric symptoms in depressed women.
199116 citationsauthor #2
Cerebral laterality and depression: relations of perceptual asymmetry to outcome of treatment with tricyclic antidepressants.
199036 citationsauthor #4
Effect of imipramine on depression and immune status in a sample of men with HIV infection.
199013 citationsauthor #2
Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
1990146 citationsauthor #4
A placebo-controlled trial of L-deprenyl in atypical depression.
198943 citationsauthor #3
MAOIs and hypertensive crises: the role of OTC drugs.
198934 citationsauthor #1
Cerebral laterality and depression: differences in perceptual asymmetry among diagnostic subtypes.
1989158 citationsauthor #6
Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria.
198989 citationsauthor #1
Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
1989119 citationsauthor #4
Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression.
198974 citationsauthor #7
Treatment of premenstrual depression with nortriptyline: a pilot study.
198943 citationsauthor #1
Cilobamine in the treatment of atypical depression
19883 citationsauthor #5
Is loss of antidepressant effect during continuation therapy related to placebo effect?
19884 citationsauthor #1
Antidepressant specificity in atypical depression.
1988317 citationsauthor #5
Tyramine sulfate excretion may be a better predictor of antidepressant response than monoamine oxidase activity.
198814 citationsauthor #2
Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
1988179 citationsauthor #5
Decreased Tyramine Conjugation in Melancholia: A Trait Marker
19880 citationsauthor #2
Validity assessment of SAFTEE: a preliminary report.
19878 citationsauthor #6
Treatment of premenstrual dysphoria with alprazolam and placebo.
198732 citationsauthor #1
Use of pattern analysis to identify true drug response. A replication.
1987207 citationsauthor #6
A Comparative Study of the Electrocardiographic Effects of Phenelzine, Tricyclic Antidepressants, Mianserin, and Placebo
198711 citationsauthor #4
Potentiation of antidepressants by T3 and lithium.
19870 citationsauthor #1
Baseline characteristics of 10-day placebo washout responders in antidepressant trials.
198750 citationsauthor #5
Effects of antidepressant medication on sexual function: a controlled study.
1986194 citationsauthor #1
How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine.
1986114 citationsauthor #5
Study duration in antidepressant research: advantages of a 12-week trial.
198629 citationsauthor #5
Follow-up of patients who improved during placebo washout.
198622 citationsauthor #4
Treatment of Atypical Depression: Phenelzine, Imipramine, and Placebo
19860 citationsauthor #5
Phenelzine for chronic depression: a study of continuation treatment.
198666 citationsauthor #1
Lactate infusion in patients with depression and anxiety.
198515 citationsauthor #3
Sleep of atypical depressives.
198544 citationsauthor #5
A controlled study of the effects of antidepressants on sexual function.
198530 citationsauthor #1
Placebo-controlled study of mianserin in depressed outpatients.
198519 citationsauthor #4
Adverse Reactions to Monoamine Oxidase Inhibitors. Part II. Treatment Correlates and Clinical Management
198583 citationsauthor #4
Effect of panic attacks on the treatment of atypical depressives.
198512 citationsauthor #5
Psychiatric evaluation of premenstrual changes.
198527 citationsauthor #1
Phenelzine versus imipramine in atypical depression: a preliminary report
198525 citationsauthor #5
Treatment of prementstrual symptoms
198529 citationsauthor #1
Treatment of premenstrual symptoms.
19852 citationsauthor #1
Treatment outcome validation of DSM-III depressive subtypes. Clinical usefulness in outpatients with mild to moderate depression.
198558 citationsauthor #4
Low B6 levels in depressed outpatients.
198429 citationsauthor #2
Phenelzine v imipramine in atypical depression. A preliminary report.
1984228 citationsauthor #5
The tyramine challenge test as a marker for melancholia.
198453 citationsauthor #1
Treatment of premenstrual dysphoric changes: clinical outcome and methodological implications.
198426 citationsauthor #1
Adverse Reactions to Monoamine Oxidase Inhibitors. Part I. A Comparative Study
198480 citationsauthor #3
Psychopharmacological dissection of nonendogenous depression.
19842 citationsauthor #5
Psychopharmacologic validation of atypical depression.
198411 citationsauthor #5
The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
198446 citationsauthor #5
Biochemical Effects and Antidepressant Mechanisms of L-Deprenyl
19840 citationsauthor #6
Unusual Side Effects of Clomipramine Associated with Yawning
198434 citationsauthor #1
Phenelzine‐Induced Pyridoxine Deficiency
198421 citationsauthor #2
Cortisol response to dextroamphetamine stimulation in depressed outpatients.
19848 citationsauthor #5
Treatment of melancholia with tranylcypromine.
198424 citationsauthor #3
Treatment of melancholia with tranylcypromine
198413 citationsauthor #3
l-Deprenyl in atypical depressives.
198484 citationsauthor #5
Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness.
1983100 citationsauthor #5
Antidepressants and Stimulants: Efficacy of desipramine in depressed outpatients, response according to Research Diagnostic Criteria diagnoses and severity of illness
19832 citationsauthor #5
Treatment of bulimia with monoamine oxidase inhibitors.
198322 citationsauthor #4
Case report of carpal tunnel syndrome associated with tranylcypromine.
19833 citationsauthor #1
Treatment of Bulimia with Monoamine Oxidase Inhibitors
198277 citationsauthor #4
Book reviewTextbook of Radiologic Technology. By JacobiC. A. and ParisD. Q., 6th edn. pp. X + 559, illus., 1977 (U.S.A. C. V. Mosby Co.; London. Henry Kimpton), £14·25.
19780 citationsauthor #1
Book reviewComprehensive Review for the Radiological Technologist. By StevensMatthew and PhillipsRobert I., pp. viii + 243, 3rd Ed, 1977 (The C. V. Mosby Company: & London; Henry Kempton), £6·10.
19770 citationsauthor #1

TIMELINE

1977 0 citations

1978 0 citations

1982 77 citations

1983 127 citations

1984 659 citations

1985 344 citations

1986 425 citations

1987 308 citations

1988 517 citations

1989 560 citations

1990 195 citations

1991 120 citations

1992 67 citations

1993 342 citations

1994 343 citations

1995 179 citations

1996 199 citations

1997 650 citations

1998 527 citations

1999 164 citations

2000 1,149 citations

2001 161 citations

2002 1,674 citations

2003 417 citations

2018 6 citations

COAUTHOR MAP

CONCEPT FOOTPRINT